View in EDS HTML Full Text PDF Full Text

Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.

Saved in:
Bibliographic Details
Title: Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
Authors: Roux, Perrine (AUTHOR), Faye, Aissatou (AUTHOR), Sagaon‐Teyssier, Luis (AUTHOR), Donadille, Cécile (AUTHOR), Briand Madrid, Laélia (AUTHOR), Carrieri, Maria Patrizia (AUTHOR), Maradan, Gwenaelle (AUTHOR), Jauffret‐Roustide, Marie (AUTHOR), Lalanne, Laurence (AUTHOR), Auriacombe, Marc (AUTHOR)
Source: Drug & Alcohol Review. Jan2025, Vol. 44 Issue 1, p275-287. 13p.
Subjects: Stimulants, Opioids, Buprenorphine, Intravenous drug abusers, Morphine, Methadone treatment programs, Cohort analysis
Geographic Terms: France
Abstract: Introduction: The co‐use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectiveness among people with opioid use disorder. However, few data exist on stimulant‐opioid co‐use among people receiving OAT. Using data from the COSINUS cohort study, we investigated the association between the type of OAT and problematic stimulant use among persons who inject drugs (PWID). Methods: COSINUS is a 12‐month French cohort study of 665 PWID. Data were collected in face‐to‐face interviews at enrolment, at 6 and 12 months. We defined problematic stimulant use as daily use of and/or injecting stimulants. We used Bayesian model averaging (BMA) to identify factors associated with problematic stimulant use. Results: At baseline, 76% (n = 505) of the participants reported problematic stimulant use. The optimal model from the BMA estimation showed that, after adjusting on social precarity and daily injection, participants on prescribed morphine sulfate as an OAT (compared with methadone) and those who use daily unprescribed buprenorphine were less likely to report problematic stimulant use. Discussion and Conclusions: Our work highlights the high prevalence of problematic stimulant use among PWID in France but also the potential association between the type of OAT taken and stimulant use, by suggesting a protective effect of morphine sulfate on stimulant use. Since it has a higher intrinsic activity than other opioids, PWID on this OAT may be less interested in stimulants. Our findings warrant further investigation in clinical studies. [ABSTRACT FROM AUTHOR]
Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 183913575
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Roux%2C+Perrine%22">Roux, Perrine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Faye%2C+Aissatou%22">Faye, Aissatou</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sagaon‐Teyssier%2C+Luis%22">Sagaon‐Teyssier, Luis</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Donadille%2C+Cécile%22">Donadille, Cécile</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Briand+Madrid%2C+Laélia%22">Briand Madrid, Laélia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carrieri%2C+Maria+Patrizia%22">Carrieri, Maria Patrizia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maradan%2C+Gwenaelle%22">Maradan, Gwenaelle</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jauffret‐Roustide%2C+Marie%22">Jauffret‐Roustide, Marie</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lalanne%2C+Laurence%22">Lalanne, Laurence</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Auriacombe%2C+Marc%22">Auriacombe, Marc</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Drug+%26+Alcohol+Review%22">Drug & Alcohol Review</searchLink>. Jan2025, Vol. 44 Issue 1, p275-287. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Stimulants%22">Stimulants</searchLink><br /><searchLink fieldCode="DE" term="%22Opioids%22">Opioids</searchLink><br /><searchLink fieldCode="DE" term="%22Buprenorphine%22">Buprenorphine</searchLink><br /><searchLink fieldCode="DE" term="%22Intravenous+drug+abusers%22">Intravenous drug abusers</searchLink><br /><searchLink fieldCode="DE" term="%22Morphine%22">Morphine</searchLink><br /><searchLink fieldCode="DE" term="%22Methadone+treatment+programs%22">Methadone treatment programs</searchLink><br /><searchLink fieldCode="DE" term="%22Cohort+analysis%22">Cohort analysis</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22France%22">France</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Introduction: The co‐use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectiveness among people with opioid use disorder. However, few data exist on stimulant‐opioid co‐use among people receiving OAT. Using data from the COSINUS cohort study, we investigated the association between the type of OAT and problematic stimulant use among persons who inject drugs (PWID). Methods: COSINUS is a 12‐month French cohort study of 665 PWID. Data were collected in face‐to‐face interviews at enrolment, at 6 and 12 months. We defined problematic stimulant use as daily use of and/or injecting stimulants. We used Bayesian model averaging (BMA) to identify factors associated with problematic stimulant use. Results: At baseline, 76% (n = 505) of the participants reported problematic stimulant use. The optimal model from the BMA estimation showed that, after adjusting on social precarity and daily injection, participants on prescribed morphine sulfate as an OAT (compared with methadone) and those who use daily unprescribed buprenorphine were less likely to report problematic stimulant use. Discussion and Conclusions: Our work highlights the high prevalence of problematic stimulant use among PWID in France but also the potential association between the type of OAT taken and stimulant use, by suggesting a protective effect of morphine sulfate on stimulant use. Since it has a higher intrinsic activity than other opioids, PWID on this OAT may be less interested in stimulants. Our findings warrant further investigation in clinical studies. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183913575
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dar.13955
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 275
    Subjects:
      – SubjectFull: Stimulants
        Type: general
      – SubjectFull: Opioids
        Type: general
      – SubjectFull: Buprenorphine
        Type: general
      – SubjectFull: Intravenous drug abusers
        Type: general
      – SubjectFull: Morphine
        Type: general
      – SubjectFull: Methadone treatment programs
        Type: general
      – SubjectFull: Cohort analysis
        Type: general
      – SubjectFull: France
        Type: general
    Titles:
      – TitleFull: Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roux, Perrine
      – PersonEntity:
          Name:
            NameFull: Faye, Aissatou
      – PersonEntity:
          Name:
            NameFull: Sagaon‐Teyssier, Luis
      – PersonEntity:
          Name:
            NameFull: Donadille, Cécile
      – PersonEntity:
          Name:
            NameFull: Briand Madrid, Laélia
      – PersonEntity:
          Name:
            NameFull: Carrieri, Maria Patrizia
      – PersonEntity:
          Name:
            NameFull: Maradan, Gwenaelle
      – PersonEntity:
          Name:
            NameFull: Jauffret‐Roustide, Marie
      – PersonEntity:
          Name:
            NameFull: Lalanne, Laurence
      – PersonEntity:
          Name:
            NameFull: Auriacombe, Marc
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09595236
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Drug & Alcohol Review
              Type: main
ResultId 1